Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Fowell

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Advances in Therapy|July 24, 2010
Telaprevir: a new hope in the treatment of chronic hepatitis C?Andrew J Fowell, Kathryn L Nash
Digestive Diseases (Basel, Switzerland)|May 16, 2006
Emerging therapies for liver fibrosisAndrew J Fowell, John P Iredale
Liver International : Official Journal of the International Association for the Study of the Liver|July 24, 2008
Renal hepatitis C in the absence of detectable serum or hepatic virusAndrew J Fowell, Nicholas Sheron, William M C Rosenberg
Frontline Gastroenterology|March 15, 2024
Novel, nurse-led early postdischarge clinic is associated with fewer readmissions and lower mortality following hospitalisation with decompensated cirrhosisBenjamin Giles, Kirsty Fancey, Karen Gamble, et al.
Frontline Gastroenterology|February 22, 2021
Evaluation of a primary to secondary care referral pathway and novel nurse-led one-stop clinic for patients with suspected non-alcoholic fatty liver diseaseAndrew J Fowell, Kirsty Fancey, Karen Gamble, et al.
Biochemical and Biophysical Research Communications|February 9, 2011
Silencing tissue inhibitors of metalloproteinases (TIMPs) with short interfering RNA reveals a role for TIMP-1 in hepatic stellate cell proliferationAndrew J Fowell, Jane E Collins, Dale R Duncombe, et al.
Gastroenterology|January 29, 2020
Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver DiseaseEleonora Scorletti, Paul R Afolabi, Elizabeth A Miles, et al.
Nature Communications|March 3, 2023
Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humansKodihalli C Ravindra, Vishal S Vaidya, Zhenyu Wang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Advances in Therapy|July 24, 2010
Telaprevir: a new hope in the treatment of chronic hepatitis C?Andrew J Fowell, Kathryn L Nash
Digestive Diseases (Basel, Switzerland)|May 16, 2006
Emerging therapies for liver fibrosisAndrew J Fowell, John P Iredale
Liver International : Official Journal of the International Association for the Study of the Liver|July 24, 2008
Renal hepatitis C in the absence of detectable serum or hepatic virusAndrew J Fowell, Nicholas Sheron, William M C Rosenberg
Frontline Gastroenterology|March 15, 2024
Novel, nurse-led early postdischarge clinic is associated with fewer readmissions and lower mortality following hospitalisation with decompensated cirrhosisBenjamin Giles, Kirsty Fancey, Karen Gamble, et al.
Frontline Gastroenterology|February 22, 2021
Evaluation of a primary to secondary care referral pathway and novel nurse-led one-stop clinic for patients with suspected non-alcoholic fatty liver diseaseAndrew J Fowell, Kirsty Fancey, Karen Gamble, et al.
Biochemical and Biophysical Research Communications|February 9, 2011
Silencing tissue inhibitors of metalloproteinases (TIMPs) with short interfering RNA reveals a role for TIMP-1 in hepatic stellate cell proliferationAndrew J Fowell, Jane E Collins, Dale R Duncombe, et al.
Gastroenterology|January 29, 2020
Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver DiseaseEleonora Scorletti, Paul R Afolabi, Elizabeth A Miles, et al.
Nature Communications|March 3, 2023
Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humansKodihalli C Ravindra, Vishal S Vaidya, Zhenyu Wang, et al.
Pageof 1